T
Todd J. Schwedt
Researcher at Mayo Clinic
Publications - 205
Citations - 14369
Todd J. Schwedt is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Migraine & Medicine. The author has an hindex of 39, co-authored 173 publications receiving 11852 citations. Previous affiliations of Todd J. Schwedt include University of Washington & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache
Jill C Rau,Edita Navratilova,Janice Oyarzo,Kirk W. Johnson,Sheena K. Aurora,Todd J. Schwedt,David W. Dodick,Frank Porreca,Frank Porreca +8 more
TL;DR: In a pre-clinical rat model of MOH, oral lasmiditan, like sumatriptan, induced acute transient cutaneous allodynia in the periorbital and hindpaw regions that after resolution could be re-evoked by putative migraine triggers.
Journal ArticleDOI
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial:
Todd J. Schwedt,Richard B. Lipton,Jessica Ailani,Stephen D. Silberstein,Cristina Tassorelli,Hua Guo,Kaifeng Lu,Brett Dabruzzo,Rosa Miceli,Lawrence Severt,Michelle Finnegan,Joel M Trugman +11 more
TL;DR: Atogepant as discussed by the authors is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist for the preventive treatment of migraines.
Journal ArticleDOI
Thunderclap Headaches: A Focus on Etiology and Diagnostic Evaluation
TL;DR: “Primary thunderclap headache” is diagnosed when a complete evaluation fails to identify a specific cause for thunderclapp headache.
Journal ArticleDOI
ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They?
TL;DR: Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, ACE inhibitors and ARBs are considered as second- or third-line options for migraine prophylaxis.
Journal ArticleDOI
Migraine Subclassification via a Data‐Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements
TL;DR: The current subclassification of migraine is according to headache frequency and aura status, and the variability in migraine symptoms, disease course, and response to treatment suggest the presence of additional heterogeneity or subclasses within migraine.